Physician profile
Aaron J Turnquist
NPI 1649776345
$3,181.33
in general payments reported to CMS, 2019-2025
28 companies · $943 in 2025
The $943 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $43.16 · 2023: $800 · 2024: $1,396 · 2025: $943.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,138.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $687.31 | 2023-2025 | Orgovyx, Gemtesa |
| Teleflex LLC | $264.91 | 2023-2025 | Urolift, Barrigel |
| Axonics, INC. | $249.00 | 2023-2024 | Axonics |
| Merck Sharp & Dohme LLC | $240.57 | 2023-2025 | Lynparza, Keytruda, Welireg |
| Janssen Biotech, INC. | $143.09 | 2023-2024 | Erleada, Akeega, Balversa |
| Myriad Genetic Laboratories, INC. | $141.89 | 2023-2025 | Prolaris |
| Ferring Pharmaceuticals INC. | $131.24 | 2024-2025 | Adstiladrin |
| Progenics Pharmaceuticals, INC. | $126.73 | 2023-2025 | Pylarify |
| Coloplast Corp | $126.15 | 2023-2025 | Speedicath, Titan |
| Astellas Pharma US INC | $121.78 | 2022-2025 | Myrbetriq, Xtandi |
| Bayer Healthcare Pharmaceuticals INC. | $119.23 | 2024-2025 | |
| Innovation Technologies INC | $114.23 | 2023 | Irrisept |
| Medtronic, INC. | $111.55 | 2023-2025 | Interstim |
| Urogen Pharma, INC. | $108.01 | 2024-2025 | |
| Endo USA, INC. | $60.24 | 2025 | Xiaflex, Aveed |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $59.84 | 2023-2024 | Xiaflex, Aveed |
| Tolmar, INC. | $54.79 | 2024-2025 | Jatenzo |
| Boston Scientific Corporation | $48.30 | 2025 | Axonics |
| Pfizer INC. | $47.91 | 2024 | |
| Accord Healthcare, INC. | $41.28 | 2023-2025 | |
| Blue Earth Diagnostics | $26.84 | 2025 | Posluma |
| Antares Pharma, INC. | $25.38 | 2024 | Xyosted |
| Immunitybio, INC. | $24.45 | 2024 | |
| Calyxo, INC. | $24.17 | 2025 | Cvac Aspiration System |
| Valencia Technologies Corporation | $23.81 | 2025 | Ecoin Device Kit |
| Abbvie INC. | $22.19 | 2025 | |
| Photocure INC | $21.39 | 2024 | Cysview |
| 180 Medical, INC. | $15.05 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Turnquist listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.